WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

about

Diabetes and dyslipidemia: characterizing lipoprotein metabolism.

P2860

Q41283425-7E333989-1C03-4364-A175-505589AB0891

P2860

WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

Item

http://www.wikidata.org/entity/Q36930204

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

WAT apoC-I secretion: role in ...... vivo in WAT in obese subjects.

@en

type

Item

label

WAT apoC-I secretion: role in ...... vivo in WAT in obese subjects.

@en

prefLabel

WAT apoC-I secretion: role in ...... vivo in WAT in obese subjects.

@en

P1476

WAT apoC-I secretion: role in ...... vivo in WAT in obese subjects.

@en

P2093

Hanny Wassef

http://www.w3.org/2001/XMLSchema#string

Jean Davignon

http://www.w3.org/2001/XMLSchema#string

May Faraj

http://www.w3.org/2001/XMLSchema#string

Simon Bissonnette

http://www.w3.org/2001/XMLSchema#string

Valerie Lamantia

http://www.w3.org/2001/XMLSchema#string

Yannick Cyr

http://www.w3.org/2001/XMLSchema#string

P2860

Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity

Exact localization of the familial dysbetalipoproteinemia associated HpaI restriction site in the promoter region of the APOC1 gene

Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

P304

1074-1085

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.P064170

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27040450

http://www.w3.org/2001/XMLSchema#string

P932

4878191

http://www.w3.org/2001/XMLSchema#string

WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

about

P2860

P2860

WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932